Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 133
  • Home
  • Print this page
  • Email this page
Year : 2016  |  Volume : 2  |  Issue : 1  |  Page : 8-13

Haploidentical stem cell transplant: Established treatment, expanding horizons

Hemato-oncology and BMT Unit, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India

Correspondence Address:
Dinesh Bhurani
Hemato-oncology and BMT Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2454-6798.180583

Rights and Permissions

Haploidentical stem cell transplantation offers an oppurtunity for transplant for almost all patients for whom transplant is indicated. Traditionally, it is associated with higher incidence of graft failure, graft vs host disease and non relapse mortality as compared to matched donor transplant. However, recent advances in the field have tried to mitigate these issues and offer haploidentical transplant as a safe and viable option. In this review, we shall discuss the basics of haploidentical transplantation, how to choose the best donor amongst various haploidentical donors available and understand the various recent advances in the field of haploidentical transplantation and how they addressed the problems associated with it and make it a feasible alternative to matched sibling or unrelated transplant in various diseases.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded457    
    Comments [Add]    

Recommend this journal